LBNL Logo ONHS Funding Opportunity Report

BROAD AGENCY ANNOUNCEMENT (BAA) RESEARCH AND DEVELOPMENT IN SUPPORT OF THE JOINT PROGRAM EXECUTIVE OFFICE FOR CHEMICAL, BIOLOGICAL, RADIOLOGICAL AND NUCLEAR DEFENSE (JPEO-CBRND), JPM MEDICAL AND JPL EB

Solicitation ID: CBRND-BAA-22-01

Agency: JPEO-CBRND/JPM MEDICAL and JPL EB

Type: Solicitation
Deadline: 2030-12-31T23:59:00 ET
Eligibility: Maybe (Unspecified)
Funding: N/A
Doc Type: BAA
Clearance: No
Program Manager: usarmy.detrick.dod-jpeo-cbrnd.mbx.baa@army.mil
Last Updated: 2026-03-25 16:02
Analyzed File: API_Description.txt

Eligibility Reasoning

Eligibility for FFRDCs or National Labs was not mentioned.

Note: This is an AI-generated summary...

Summary

[Analyzed from API Fallback] The Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) is soliciting research and development proposals through a Broad Agency Announcement (BAA). The BAA seeks to identify the best available science from educational institutions, non-profits, and private industry. While open to unsolicited proposals within its mission areas, the BAA has a specific interest in novel solutions for the rapid development of medical countermeasures, focusing on enabling technologies, life cycle bioinformatics, and improved logistics tracking. Potential offerors are encouraged to discuss their ideas with technical contacts before submission.

Overall Technical Areas

Chemical Defense ResearchBiological Defense ResearchRadiological Defense ResearchNuclear Countermeasure DevelopmentMedical Countermeasure DevelopmentLife Cycle BioinformaticsRapid Development MethodsNovel Enabling TechnologiesComputational BiologyGenomic and Proteomic AnalysisAdvanced DiagnosticsTherapeutic Development

Probable LBNL Areas

BSACSAESAETA

Focus Areas

Example Priorities:
  • Studies related to novel solutions and improved methods to develop medical countermeasures more rapidly and with increased efficiency through enabling technologies
  • life cycle bioinformatics
  • improved logistics tracking
Specific Technical Skills:
Medical CountermeasuresCBRN DefensePharmaceutical DevelopmentBiotechnologyEnabling TechnologiesBioinformaticsComputational BiologyLogistics ManagementSupply Chain OptimizationData Science
Potential PIs for this Area:
NameScoreOrganization
Thomas Hendrickson0.72ETA | Energy Analysis & Env. Impacts | Sustainable Energy Dept
Hector Garcia Martin0.70BSA | Biological Systems & Engineering | Process Engr & Analytics
Thomas Eng0.69BSA | Biological Systems & Engineering | Biodesign Dept
Aeron Tynes Hammack0.69ESA | MF | MF Nanofabrication Facility
Eileen Dawson0.69CSA | AMCR | Computer Science
Oluwamayowa Amusat0.69CSA | SciData | Data Science Applications
Chang Dou0.69BSA | Biological Systems & Engineering | Process Engr & Analytics
Ana Comesana0.68ETA | Building Tech. & Urban Sys. | Bldg & Industrial App Dpt
Gazi Mahmud0.68BSA | Env. Genomics & Sys. Biology | Molecular Ecosystems Bio
Aindrila Mukhopadhyay0.68BSA | Biological Systems & Engineering | Biodesign Dept

Potential LBNL PIs (Overall)

Note on PI Matching: These suggestions are generated through an AI-driven semantic analysis of LBNL staff profiles.

NameScoreOrganization
Morgan Price0.76BSA | Env. Genomics & Sys. Biology | Comparative and Funct Genomics · Computational Biology
Harshini Mukundan0.75LD | LD | ONHS · Biological Defense Research
Victor Negut0.75PSA | NSD | ANP · Radiological Defense Research
Adam Deutschbauer0.74BSA | Env. Genomics & Sys. Biology | Comparative and Funct Genomics · Genomic and Proteomic Analysis
Emil Rofors0.74PSA | NSD | ANP · Nuclear Countermeasure Development
Steven Hofmeyr0.74CSA | AMCR | Computer Science · Life Cycle Bioinformatics
Ryan Heller0.74PSA | NSD | ANP · Advanced Diagnostics
Gerard Marriott0.73BSA | Molecular Biophysics & Integrated Bioimaging | Cellular & Tissue Image · Therapeutic Development
Natalia Molchanova0.73ESA | MF | MF Biological Facility · Medical Countermeasure Development
Ravi Prasher0.73ETA | ESDR | Energy Storage & Dist Dpt · Novel Enabling Technologies

Fundamental Research Exemption (FRE)

Not Mentioned